The present disclosure relates to copending and commonly assigned U.S. patent application Ser. No. 11/941,840, entitled “Flow Pulsatility Dampening Devices For Closed-Loop Controlled Infusion System”, filed Nov. 16, 2007.
The present disclosure generally relates to medical fluid delivery systems. In particular, the present disclosure relates to devices and methods for transforming a generally pulsatile fluid flow in an infusion system to a smoother or less pulsatile fluid flow.
Liquid medicaments and other complex medical and therapeutic fluids are often administered to patients through infusion therapy. Typically, infusion therapy is accomplished by employing an infusion pump to force fluid through an infusion circuit and into a patient. In certain situations, such as when the infusion of fluid takes place over a long period of time with a patient that is ambulatory, it is desirable to use a disposable infusion system.
Because disposable infusion systems are generally single-use items, such systems typically include relatively simple and inexpensive components. However, one of the difficulties encountered with using relatively simple and inexpensive components is that the components are often not compatible for use with one another. For example, the majority of simple and inexpensive infusion pumps generate a pulsatile or non-continuous fluid flow. Even durable and expensive pumps generate pulsatility. This pulsatile fluid flow is dynamic and has flowrate and pressure fluctuations that change very quickly. Further, most simple and inexpensive fluid flow sensors do not have the temporal resolution or the ability to sense and calculate the flowrate of a pulsatile fluid flow. The incompatibility of these components creates an obstacle to producing economical disposable infusion systems that have the ability to monitor the fluid flowrate within the infusion circuit.
In many infusion therapy applications a fluid is required to be administered to the patient at a certain fluid flowrate to be therapeutically effective. For example, in some applications, if the fluid is infused too slowly, the intended therapeutic effect may be diminished or totally non-existent. In other applications, infusion of a fluid into the body at too high a rate can create a dangerous or overdose situation. Thus, in a number of infusion therapy applications it is important for the user to be able to quickly and accurately determine the rate of fluid flow through the system, so that the flowrate can be monitored and adjusted as needed.
In those instances in which it is important for the user to be able to determine flowrate, a disposable infusion set will often include either an infusion pump that generates a smooth fluid flow or a flow sensor that has the ability to monitor and calculate the flowrate of a pulsatile or non-continuous fluid flow. One of the disadvantages of using a smooth flow generating infusion pump or a flow sensor that can monitor pulsatile flow is that both of those components are relatively expensive and add appreciably to the overall cost of the disposable infusion set. In addition to increased cost, system components that are capable of achieving high resolution measurements often require complex circuitry, hardware and software architecture.
The present disclosure provides an infusion system that includes a dampening element, which transforms a generally non-continuous or pulsatile flow of fluid within the infusion system into a generally smoother or less pulsatile fluid flow. The incorporation of a dampening element in to an infusion system provides a variety of benefits. For example, the transformation of a generally pulsatile fluid flow into a smoother fluid flow allows a relatively inexpensive fluid flow sensor, which does not have the temporal resolution to sense and calculate flowrate of a pulsatile flow of fluid, to be used to monitor and adjust such fluid flow. The ability to employ a relatively inexpensive flow sensor decreases the overall cost of the infusion system appreciably.
In general, the dampening element is disposed at a location along the fluid pathway of an infusion system and receives a fluid having a pulsatile fluid flow from a fluid source upstream of the dampening element. For example, in one embodiment a medical fluid infusion system of the present disclosure includes a fluid pathway for transporting a pulsatile flow of fluid, e.g., a drug for infusion into the patient pumped from a pulsatile infusion pump, e.g., a membrane pump or a peristaltic pump. A dampening element is placed in fluid communication with the fluid pathway. The dampening element actively dampens pressure fluctuations of the pulsatile flow to smoothen the pulsatile fluid flow. Advantageously, the dampening element can be operated in any orientation and is not gravity dependent. A fluid flow sensor is disposed along the fluid pathway downstream of the dampening element to measure the flow rate of the smoothened fluid flow. The system can provide a common enclosure housing both the dampening element and the fluid flow sensor.
Many different configurations for the dampening element are set forth in detail below. For example, the dampening element can include an outer housing holding air at atmosphere or pressurized from a compressed air source and an inner chamber holding the pumped fluid. Or, the dampening element can include an outer housing holding a rheologiz fluid and an inner chamber holding the pumped fluid. Alternatively, the dampening element includes a bellows that is expanded by the pumped fluid so as to actively provide a compressive force onto the pumped fluid. Further alternatively, the dampening element can include a flexible wall that actively provides a compressive force onto the pumped fluid. Yet further alternatively, the dampening element can include an expandable tube to actively provide a compressive force onto the pumped fluid. In still another alternative embodiment, the dampening element includes a plurality of bunched parallel tubes that actively provide a compressive force onto the pumped fluid.
In particular, one infusion system includes (i) a fluid pathway; (ii) an infusion pump for pumping a non-continuous flow of fluid through the fluid pathway; (iii) a housing enclosing an expandable membrane, an inside of the membrane defining a chamber that is in communication with the fluid pathway, an outside of the chamber within the housing containing a compressible gas that absorbs pressure fluctuations of the non-continuous flowing fluid to smoothen the non-continuous flow, the housing and the chamber operable in any orientation; and (iv) a fluid flow sensor disposed along the fluid pathway downstream of the housing, the fluid flow sensor configured to measure a flowrate of the smoothened fluid flow.
In another embodiment, a medical fluid infusion system includes (i) an infusion pump; (ii) a fluid pathway for transporting a pulsatile flow of fluid produced by the infusion pump; (iii) a fluid holding compartment having an inlet and an outlet in fluid communication with the fluid pathway; (iv) a chamber holding a compressible gas around at least substantially all of an outside surface of the fluid holding compartment so as to tend to dampen fluctuations of the pulsatile flow of fluid; and (v) a flow sensor disposed along the fluid pathway downstream from the fluid holding compartment and the chamber. Here, the inlet and the outlet of the fluid holding compartment can be arranged at least substantially parallel to one another so that the fluid has to change direction after entering the fluid holding compartment. Also, the fluid holding compartment can include an expandable balloon.
In a further embodiment, the medical fluid infusion system includes (i) an infusion pump; (ii) a fluid pathway for transporting a pulsatile flow of fluid produced by the infusion pump; (iii) a fluid holding compartment having an inlet and an outlet in fluid communication with the fluid pathway; (iv) at least one compressible air balloon located inside the fluid holding compartment that tends to dampen fluctuations of the pulsatile flow of fluid; and (v) a flow sensor disposed along the fluid pathway downstream from the fluid holding compartment. Here, the inlet and outlet of the fluid holding compartment can be (a) configured to force the flow of fluid around the at least one compressible air balloon; and (b) arranged with respect to each other such that fluid has to change direction after entering the fluid holding compartment. In one implementation, the fluid holding compartment houses a dividing wall that separates at least two of the compressible air balloons.
In still another embodiment, the medical fluid infusion system includes (i) an infusion pump that creates at least a semi-pulsatile flow of fluid; (ii) a flow sensor disposed downstream from the infusion pump; and (iii) a tube for carrying the at least semi-pulsatile flow of fluid from the infusion pump to the flow sensor, the tube enclosing at least one compressible air balloon for smoothing the flow of fluid from the pump to the flow sensor. In one implementation, the surface of the at least one air balloon is the inner wall surface of the tube.
It is accordingly an advantage of the present disclosure to provide flow dampening for an infusion pump system in which the orientation of the dampening element or dampener is immaterial.
It is another advantage of the present disclosure to provide flow dampening for an infusion pump system in which the dampening element actively dampens pressure fluctuations of the pulsatile flow to smoothen the pulsatile fluid flow.
Additional features and advantages are described herein, and will be apparent from, the following Detailed Description and the figures.
Referring now to the drawings and in particular to
The infusion pump 14 is a pump that generates a pulsatile fluid flow having pressure fluctuations, such as a micro-diaphragm or a peristaltic pump. For example, the pump can for example be a micro-diaphragm pump provided by thinXXS Microtechnology AG, Zweibrücken, Germany. The pump itself can be disposable. Alternatively, the fluid carrying components of the pump are disposable. These types of pumps are often small in size, generally lightweight and relatively inexpensive. The pump 14 includes an inlet port 20 for receiving fluid and an outlet port 22 for expelling fluid. The inlet port 20 of the infusion pump 14 is connected to the distal end portion 24 of a fluid supply conduit 26, and the proximal end portion 28 of the fluid supply conduit 26 is connected to fluid supply 12. The connection between the fluid supply conduit 26 and the pump 14, and other connections of components described herein, can be any suitable type of permanent or removable connection known to those skilled in the art, such as a male-female luer type connection or an integral connection.
The fluid supply 12 may include a flexible dispensing bag 30 containing a fluid 18 to be infused into the patient. The dispensing bag 30 in an embodiment is made from a polymeric material and includes outlet port 32 that is connected to the proximal end portion 28 of fluid supply conduit 26. The dispensing bag 30 supplies the fluid 18 through the fluid supply conduit 26 to the infusion pump 14.
Infusion pathway 16 provides a fluid path from the pump 14 to an infusion device such as a cannula or catheter (not shown). Infusion pathway 16 can include a first fluid conduit 34 that has a proximal end portion 36 and a distal end portion 38. Proximal end portion 36 of first fluid conduit 34 is connected to outlet port 22 of infusion pump 14 and receives a pulsatile flow of fluid from the infusion pump. For example, the rollers of a race of a peristaltic pump create a generally pulsatile flow. The back and forth motion of a membrane or diaphragm in a membrane pump also creates non-continuous or pulsatile flow.
A pulsatility dampening device or element (referring to any of the dampeners 80, 90, 100a/100b, 120, 130, 140, 150, 160, 170, 180 and 190 described herein) is disposed along infusion pathway 16 at a location that is downstream of the infusion pump 14. Distal end portion 38 of first fluid conduit 34 is connected to the dampening element. The dampening element receives the pulsatile fluid flow and transforms it into a smoother or more continuous fluid flow.
Referring now to
Referring now to
When the positive position of the pressure spikes subsides leading to a negative slope of the pressure pulse, such that the solid flow line “Flow (Q) without dampener” would if not dampened fall below the dotted desired dampened flow line “Flow (Q) with dampener”, and create a negative volume −dv. The provision of a dampener however allows its expandable and/or flexible material to deflect, giving back stored volume +dv and negating negative volume −dv to smoothen the up to the desired flowrate “Flow (Q) with dampener”. The pulsatile pulse cycle just discussed is then repeated per the cyclical nature of the pulsatile flow.
Referring now to
Inlet 84 and outlet 86 can be made of any suitable medical grade tubing. Inlet 84 and outlet 86 are alternatively formed integrally with dampening element 88, which is made of a medical grade material that is expandable and compressible. Examples of the medical grade material include: medical grade thermoset elastomers, silicone rubbers, and butyl rubbers. Dampening element 88 swells upon seeing a positive pressure spike to absorb extra volume +dv over each pulsatile pressure pulse illustrated in
Referring now to
Dampener 90 replaces balloon or sack-like chamber 88 above, which expands and compresses radially and spherically, with flexible wall 98, which flexes away from and towards inlet 94 and outlet 96 in a bow-like manner. Flexible wall 98 can be made of any of the materials discussed above for dampening element 88. Upon a positive pulsatile pressure spike, flexible wall 98 bowes or flexes to absorb the extra volume +dv. Flexible wall 98 then un-bowes or un-flexes to a flat condition upon the depressurization of the pulsatile pressure spike, so as to give back positive +dv volume through outlet 96. Giving back the +dv volume through outlet 96 makes up for the lack of volume −dv caused by the negative portion of the pressure spike (see
Referring now to
Each housing 102a and 102b houses a highly compressible dampening pouch or balloon 108, forming a dampening element, which is made of a flexible e.g., plastic membrane. Pouch or balloon 108 can be filled with air or a compressible gel. Medical fluid flows around and in contract with balloon 108 as it travels from inlet 104 to outlet 106. In an embodiment, balloon 108 is sized and position so as to have maximum surface area contact with the medical fluid to optimize its dampening effect. Balloon 108 can have a spherical, oval, elliptical or other suitable shape. In one preferred embodiment, balloon 108 is positioned upstream of flow sensor 50.
Upon a positive pulsatile pressure spike, balloon or pouch 108 compresses to absorb the extra volume +dv. Balloon or pouch 108 then decompresses to its natural volume upon the depressurization of the pulsatile pressure spike so as to give back the +dv volume through outlet 106. Giving back the +dv volume makes up for the lack of volume −dv caused by the negative position of the pressure spike (see
Referring now to
Housing 122 holds a plurality of compressible air bags or balloons 128, forming a dampening element. In the illustrated embodiment, balloons 128 are split on each side of divider wall 129. Alternatively, divider wall 129 is not provided. As with balloon or pouch 108, balloons or pouches 128 can be filled with air or a compressible gel. Balloons 129 individually and collectively dampen pulsatile medical fluid flow along the outside surfaces of the balloons in a manner consistent with balloon or pouch 108 of dampeners 100a and 100b of
Referring now to
Tubing 132 holds dampening pouches or balloons 138, forming a dampening element, which operate as described above to dampen pulsatile pressure spikes by compressing and decompressing as medical fluid flows in a pulsatile manner around the balloons. Pouches or balloons 138 can be formed separate from tube 132 or be formed as part of the tube. In the latter instance, for example, balloons 138 can be formed as blister pack or bubble wrap type structures on the inner wall of tube 132.
Referring now to
Referring now to
Balloons housing includes a plurality of accordion like pleats or walls 158, which can be made of a thin, compliant material, such as any of the materials set forth herein. Walls or pleats 158 expand outward upon seeing the positive slope of the pressure spike and retract upon seeing the negative slope of the spike. The result is a smoothened and dampened medical fluid flow over the entire pressure spike.
Referring now
Flow-through dampener 170 of
Referring now to
Referring now to
In an alternative embodiment, magneto-rheologiz material 200 is replaced by compressed air within a pressure holding housing 192, which surrounds flexible chamber 198 for dampening purposes. The compressed air can be from a cylinder, house air or via a pump of infusion pump 14. Compressed air may be injected alternatively into air chamber 89 and/or 99 of dampeners 80 and 90 above in
If air/gas is used by any of the dampeners discussed herein (either case in which medical fluid flows outside of or inside of a flexible air retaining membrane) as shown in the concepts/embodiments described later, the relationship between the stored fluid volume “dv” shown in
Po*Vo=Pf*Vf=Constant (Eq1)
in which
Po=Original pressure of uncompressed air/gas
Pf=Final pressure of compressed air/gas
Vo=Original volume of uncompressed air/gas
Vf=Final volume of compressed air/gas
Since Vf=Vo−dv by definition, substituting Vf in Eq1 yields
Po*Vo=Pf*(Vo−dv)
Po*Vo=Pf*Vo−Pf*dv
Vo=Pf*dv/(Pf−Po) or (Eq2)
dv=Vo*(Pf−Po)/Pf (Eq3)
where Eq2 and Eq3 can be used to determine the volume of air/gas and stored fluid respectively. The total volume “dv” of air/gas needed can be divided/distributed into a suitable number of shapes, forms, or inserts as shown above to create a compact or easily manufactured dampener as shown in the concepts/embodiments described later.
Aspects of the subject matter described herein may be useful alone or in combination one or more other aspect described herein. Without limiting the foregoing description, in a first aspect of the present disclosure, a medical fluid infusion system includes: a fluid pathway for transporting a pulsatile flow of fluid; a dampening element in communication with the fluid pathway, the dampening element configured to actively dampen pressure fluctuations of the pulsatile flow to smoothen the pulsatile fluid flow, the dampening element operable in any orientation; and a fluid flow sensor disposed along the fluid pathway downstream of the dampening element to measure the flowrate of the smoothened fluid flow.
In accordance with a second aspect of the present disclosure, which may be used in combination with the first aspect, the infusion includes a pulsatile infusion pump in communication with the fluid pathway, the infusion pump causing the pulsatile fluid flow.
In accordance with a third aspect of the present disclosure, which may be used in combination with the second aspect, the infusion includes a control member operable with the fluid flow sensor and the infusion pump, the control member configured to receive flowrate information from the flow sensor and to adjust the infusion pump based on the flowrate information.
In accordance with a fourth aspect of the present disclosure, which may be used in combination with any one or more of the preceding aspects, the dampening element includes an outer chamber holding air compressed from a compressed air source and an inner chamber holding the pumped fluid.
In accordance with a fifth aspect of the present disclosure, which may be used in combination with any one or more of the preceding aspects, the dampening element includes an outer chamber holding a rheologiz fluid and an inner chamber holding the pumped fluid.
In accordance with a sixth aspect of the present disclosure, which may be used in combination with any one or more of the preceding aspects, the dampening element includes a plurality of pockets formed on an inner wall of a section of tubing to actively provide a dampening force onto the pumped fluid.
In accordance with a seventh aspect of the present disclosure, which may be used in combination with any one or more of the preceding aspects, the dampening element includes a bellows that is expanded by the pumped fluid so as to actively provide a dampening force onto the pumped fluid.
In accordance with an eighth aspect of the present disclosure, which may be used in combination with any one or more of the preceding aspects, the dampening element includes a coiled section of tubing to actively provide a dampening force onto the pumped fluid.
In accordance with a ninth aspect of the present disclosure, which may be used in combination with any one or more of the preceding aspects, the dampening element includes a flexible wall to actively provide a dampening force onto the pumped fluid.
In accordance with a tenth aspect of the present disclosure, which may be used in combination with any one or more of the preceding aspects, the dampening element includes an expandable tube to actively provide a dampening force onto the pumped fluid.
In accordance with an eleventh aspect of the present disclosure, which may be used in combination with any one or more of the preceding aspects, the dampening element includes a plurality of bunched parallel tubes to actively provide a dampening force onto the pumped fluid.
In accordance with a twelfth aspect of the present disclosure, which may be used in combination with any one or more of the preceding aspects, an infusion system includes: a fluid pathway; an infusion pump for pumping a non-continuous flow of fluid through the fluid pathway; a housing enclosing an expandable membrane, an inside of the membrane defining a chamber that is in communication with the fluid pathway, an outside of the chamber within the housing containing a compressible gas that absorbs pressure fluctuations of the non-continuous flowing fluid to smoothen the non-continuous flow, the housing and the chamber operable in any orientation; and a fluid flow sensor disposed along the fluid pathway downstream of the housing, the fluid flow sensor configured to measure a flowrate of the smoothened fluid flow.
In accordance with a thirteenth aspect of the present disclosure, which may be used with any one or more of the preceding aspects in combination with aspect twelve, an inlet and an outlet of the chamber are arranged at least substantially parallel to one another so that the fluid has to change direction after entering the chamber.
In accordance with a fourteenth aspect of the present disclosure, which may be used with any one or more of the preceding aspects in combination with aspect twelve, the expandable membrane is an expandable balloon or an expandable wall.
In accordance with a fifteenth aspect of the present disclosure, which may be used in combination with any one or more of the preceding aspects, an infusion system includes: an infusion pump; a fluid pathway for transporting a pulsatile flow of fluid produced by the infusion pump; a fluid holding compartment having an inlet and an outlet in fluid communication with the fluid pathway; at least one compressible air balloon located inside the fluid holding compartment that tends to dampen fluctuations of the pulsatile flow of fluid; and a flow sensor disposed along the fluid pathway downstream from the fluid holding compartment.
In accordance with a sixteenth aspect of the present disclosure, which may be used with any one or more of the preceding aspects in combination with aspect fifteen, the inlet and outlet of the fluid holding compartment are configured to force the flow of fluid around the at least one compressible air balloon.
In accordance with a seventeenth aspect of the present disclosure, which may be used with any one or more of the preceding aspects in combination with aspect fifteen, the fluid holding compartment houses a dividing wall that separates at least two of the compressible air balloons.
In accordance with an eighteenth aspect of the present disclosure, which may be used with any one or more of the preceding aspects in combination with aspect fifteen, the inlet and outlet of the fluid holding compartment are arranged with respect to each other such that fluid has to change direction after entering the fluid holding compartment.
In accordance with a nineteenth aspect of the present disclosure, which may be used in combination with any one or more of the preceding aspects, an infusion system includes: a medical fluid infusion system includes: an infusion pump that creates at least a semi-pulsatile flow of fluid; a flow sensor disposed downstream from the infusion pump; and a tube for carrying the at least semi-pulsatile flow of fluid from the infusion pump to the flow sensor, the tube enclosing at least one compressible air balloon for smoothing the flow of fluid from the pump to the flow sensor.
In accordance with a twentieth aspect of the present disclosure, which may be used with any one or more of the preceding aspects in combination with aspect nineteen, a surface of the at least one air balloon is the inner wall surface of the tube.
In accordance with a twenty-first aspect of the present disclosure, any of the structure and functionality illustrated and described in connection with
In accordance with a twenty-second aspect of the present disclosure, any of the structure and functionality illustrated and described in connection with
In accordance with a twenty-third aspect of the present disclosure, any of the structure and functionality illustrated and described in connection with
In accordance with a twenty-fourth aspect of the present disclosure, any of the structure and functionality illustrated and described in connection with
In accordance with a twenty-fifth aspect of the present disclosure, any of the structure and functionality illustrated and described in connection with
In accordance with a twenty-sixth aspect of the present disclosure, any of the structure and functionality illustrated and described in connection with
In accordance with a twenty-seventh aspect of the present disclosure, any of the structure and functionality illustrated and described in connection with
In accordance with a twenty-eighth aspect of the present disclosure, any of the structure and functionality illustrated and described in connection with
In accordance with a twenty-ninth aspect of the present disclosure, any of the structure and functionality illustrated and described in connection with
In accordance with a thirtieth aspect of the present disclosure, any of the structure and functionality illustrated and described in connection with
In accordance with a thirty-first aspect of the present disclosure, any of the structure and functionality illustrated and described in connection with
In accordance with a thirty-second aspect of the present disclosure, any of the structure and functionality illustrated and described in connection with
In accordance with a thirty-third aspect of the present disclosure, any of the structure and functionality illustrated and described in connection with
In accordance with a thirty-fourth aspect of the present disclosure, any of the structure and functionality illustrated and described in connection with
It should be understood that various changes and modifications to the presently preferred embodiments described herein will be apparent to those skilled in the art. Such changes and modifications can be made without departing from the spirit and scope of the present subject matter and without diminishing its intended advantages. It is therefore intended that such changes and modifications be covered by the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
422936 | Hanson | Mar 1890 | A |
1627257 | Stevens | May 1927 | A |
2307566 | Browne | Jan 1943 | A |
2315179 | Allender | Mar 1943 | A |
2393838 | Tarbox | Jan 1946 | A |
2474512 | Bechtold et al. | Jun 1949 | A |
2565374 | Kitchel | Aug 1951 | A |
2773455 | Mercier | Dec 1956 | A |
2927658 | Slater, Jr. | Mar 1960 | A |
3252623 | Corbin et al. | May 1966 | A |
3527700 | Goldhaber | Sep 1970 | A |
3658445 | Pulman et al. | Apr 1972 | A |
3741692 | Rupp | Jun 1973 | A |
3778195 | Bamberg | Dec 1973 | A |
3804107 | Kozlov et al. | Apr 1974 | A |
3818934 | Borsanyi | Jun 1974 | A |
3902490 | Jacobsen et al. | Sep 1975 | A |
3974854 | Kurpanek | Aug 1976 | A |
3986956 | Anno | Oct 1976 | A |
4003379 | Ellinwood, Jr. | Jan 1977 | A |
4077405 | Hoerten et al. | Mar 1978 | A |
4081372 | Atkin et al. | Mar 1978 | A |
4107039 | Lindsay, Jr. et al. | Aug 1978 | A |
4191184 | Carlisle | Mar 1980 | A |
4193068 | Ziccardi | Mar 1980 | A |
4209014 | Sefton | Jun 1980 | A |
4258711 | Tucker et al. | Mar 1981 | A |
4264287 | Ishida et al. | Apr 1981 | A |
4293961 | Runge | Oct 1981 | A |
4345594 | Bisera et al. | Aug 1982 | A |
4360019 | Portner et al. | Nov 1982 | A |
4360324 | Ohara et al. | Nov 1982 | A |
4392791 | Mandroian | Jul 1983 | A |
4445829 | Miller | May 1984 | A |
4489750 | Nehring | Dec 1984 | A |
4493706 | Bolsanyi et al. | Jan 1985 | A |
4501583 | Troutner | Feb 1985 | A |
4525165 | Fischell | Jun 1985 | A |
4599165 | Chevallet | Jul 1986 | A |
4604090 | Reinicke | Aug 1986 | A |
4610702 | Krantz | Sep 1986 | A |
4653987 | Tsuji et al. | Mar 1987 | A |
4662829 | Nehring | May 1987 | A |
4671792 | Borsanyi | Jun 1987 | A |
4673391 | Kondo et al. | Jun 1987 | A |
4684368 | Kenyon | Aug 1987 | A |
4687423 | Maget et al. | Aug 1987 | A |
4687468 | Gianturco | Aug 1987 | A |
4714462 | DiDomenico | Dec 1987 | A |
4728265 | Cannon | Mar 1988 | A |
4741678 | Nehring | May 1988 | A |
4744786 | Hooven | May 1988 | A |
4767526 | Vantard | Aug 1988 | A |
4838887 | Idriss | Jun 1989 | A |
4871351 | Feingold | Oct 1989 | A |
4921477 | Davis | May 1990 | A |
4954046 | Irvin et al. | Sep 1990 | A |
4969936 | Schweigert et al. | Nov 1990 | A |
4978338 | Melsky et al. | Dec 1990 | A |
4979441 | Welch et al. | Dec 1990 | A |
5053031 | Borsanyi | Oct 1991 | A |
5057081 | Sunderland et al. | Oct 1991 | A |
5088904 | Okada | Feb 1992 | A |
5116308 | Hagiwara | May 1992 | A |
5152680 | Okada | Oct 1992 | A |
5176644 | Srisathapat et al. | Jan 1993 | A |
5183974 | Wilhelm et al. | Feb 1993 | A |
5244463 | Cordner, Jr. et al. | Sep 1993 | A |
5247434 | Peterson et al. | Sep 1993 | A |
5263935 | Hessel | Nov 1993 | A |
5290158 | Okada | Mar 1994 | A |
5387188 | Watson | Feb 1995 | A |
5421208 | Packard et al. | Jun 1995 | A |
5522998 | Polaschegg | Jun 1996 | A |
5544651 | Wilk | Aug 1996 | A |
5554011 | Bales et al. | Sep 1996 | A |
5562429 | Romstad et al. | Oct 1996 | A |
5607418 | Arzbaecher | Mar 1997 | A |
5730722 | Wilk | Mar 1998 | A |
5817076 | Fard | Oct 1998 | A |
5868168 | Mott et al. | Feb 1999 | A |
5871478 | Berrigan | Feb 1999 | A |
6058958 | Benkowski et al. | May 2000 | A |
6089837 | Cornell | Jul 2000 | A |
6159160 | Hsei et al. | Dec 2000 | A |
6234773 | Hill et al. | May 2001 | B1 |
6280408 | Sipin | Aug 2001 | B1 |
6290681 | Brown | Sep 2001 | B1 |
6305919 | Staton et al. | Oct 2001 | B1 |
6312409 | Gross | Nov 2001 | B1 |
6319245 | Berrigan | Nov 2001 | B1 |
6386046 | Mattar | May 2002 | B1 |
6471686 | Berrigan | Oct 2002 | B1 |
6537268 | Gibson et al. | Mar 2003 | B1 |
6558343 | Neftel | May 2003 | B1 |
6638263 | Theeuwes et al. | Oct 2003 | B1 |
6669455 | Welch | Dec 2003 | B2 |
6723062 | Westberg et al. | Apr 2004 | B1 |
6746606 | Pfeil et al. | Jun 2004 | B2 |
6837693 | Welch | Jan 2005 | B2 |
6861033 | Mullins et al. | Mar 2005 | B2 |
6997942 | Machold et al. | Feb 2006 | B2 |
7018361 | Gillespie, Jr. et al. | Mar 2006 | B2 |
7018375 | Berrigan | Mar 2006 | B2 |
7025750 | Brugger et al. | Apr 2006 | B2 |
7048522 | Bradford, Jr. | May 2006 | B2 |
7150711 | Nusser et al. | Dec 2006 | B2 |
7175649 | Machold et al. | Feb 2007 | B2 |
7208092 | Micheli | Apr 2007 | B2 |
7241378 | Ikeda | Jul 2007 | B2 |
7326564 | Lundell et al. | Feb 2008 | B2 |
7678070 | Kumar et al. | Mar 2010 | B2 |
20020088752 | Balschat et al. | Jul 2002 | A1 |
20020127736 | Chou et al. | Sep 2002 | A1 |
20030195454 | Wariar et al. | Oct 2003 | A1 |
20040019320 | Childers et al. | Jan 2004 | A1 |
20040082903 | Micheli | Apr 2004 | A1 |
20050038325 | Moll | Feb 2005 | A1 |
20050070883 | Brown et al. | Mar 2005 | A1 |
20060129099 | Kumar et al. | Jun 2006 | A1 |
20070135758 | Childers et al. | Jun 2007 | A1 |
20070158267 | Micheli | Jul 2007 | A1 |
20080015493 | Childers et al. | Jan 2008 | A1 |
20080287887 | Mack et al. | Nov 2008 | A1 |
20080294095 | Zacharias | Nov 2008 | A1 |
20080294098 | Sarkinen et al. | Nov 2008 | A1 |
20080300551 | Schiller et al. | Dec 2008 | A1 |
20080306436 | Edwards et al. | Dec 2008 | A1 |
20080319392 | Angel et al. | Dec 2008 | A1 |
20090069784 | Estes et al. | Mar 2009 | A1 |
20090069785 | Miller et al. | Mar 2009 | A1 |
20090112164 | Reilly et al. | Apr 2009 | A1 |
20090118681 | Molgaard-Nielsen | May 2009 | A1 |
20090131859 | DelCastillo et al. | May 2009 | A1 |
20090177148 | DelCastilio et al. | Jul 2009 | A1 |
20090177149 | Childers et al. | Jul 2009 | A1 |
20090209921 | Claude et al. | Aug 2009 | A1 |
20090234266 | Solomon et al. | Sep 2009 | A1 |
20090259183 | Chong et al. | Oct 2009 | A1 |
20090264824 | Bisch et al. | Oct 2009 | A1 |
20090299289 | Kamen et al. | Dec 2009 | A1 |
20100010447 | Luther et al. | Jan 2010 | A1 |
20100037680 | Moberg et al. | Feb 2010 | A1 |
20100076412 | Rush et al. | Mar 2010 | A1 |
20100094218 | Kriesel et al. | Apr 2010 | A1 |
20100114026 | Karratt et al. | May 2010 | A1 |
20100114028 | Rush et al. | May 2010 | A1 |
20100114040 | Schriver et al. | May 2010 | A1 |
20100228196 | Wyss | Sep 2010 | A1 |
20110060284 | Harr | Mar 2011 | A1 |
20110092894 | McGill et al. | Apr 2011 | A1 |
20110106010 | Steinbach et al. | May 2011 | A1 |
20110112488 | Shu | May 2011 | A1 |
Number | Date | Country |
---|---|---|
1960369 | Jun 1971 | DE |
0 816 677 | Jan 1998 | EP |
880192 | Oct 1961 | GB |
2181494 | Apr 1987 | GB |
2303925 | Mar 1997 | GB |
WO8401718 | May 1984 | WO |
2005025726 | Mar 2005 | WO |
2006008866 | Jan 2006 | WO |
WO2009065153 | May 2009 | WO |
Entry |
---|
International Search Report and Written Opinion for International Application No. PCT/US2009/030299 mailed on May 29, 2009. |
International Search Report and Written Opinion for PCT/US2008/066101 mailed Feb. 12, 2009. |
Non-Final Office Action for U.S. Appl. No. 11/941,840 dated Jul. 24, 2009. |
Final Office Action for U.S. Appl. No. 11/941,840 dated Feb. 8, 2010. |
Non-Final Office Action for U.S. Appl. No. 11/941,840 dated Sep. 17, 2010. |
Notification of Transmittal of the International Preliminary Report on Patentability for International Application No. PCT/US2009/047585 dated Oct. 12, 2010. |
International Search Report and Written Opinion for International Application No. PCT/US2009/047585 dated Feb. 1, 2010. |
Non-Final Office Action for U.S. Appl. No. 12/180,324 dated Aug. 12, 2010. |
Written Opinion for International Application No. PCT/US2011/023158 dated May 9, 2011. |
International Search Report for International Application No. PCT/US2011/023158 dated May 9, 2011. |
Notification of Transmittal of the International Preliminary Report on Patentability for International Application No. PCT/US2011/023158 dated Feb. 3, 2012. |
Number | Date | Country | |
---|---|---|---|
20110196303 A1 | Aug 2011 | US |